Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Refining the link between REM sleep behavior disorder and neurodegeneration: Genetic correlation, Mendelian randomization, and colocalization evidence.

Medicine·2026
Same author

Silver diamine fluoride versus conventional restorative treatment for dental caries in primary teeth of children: a meta-analysis.

Quintessence international (Berlin, Germany : 1985)·2026
Same author

Predictive Value of Combined MEWS and NIPDS Scores for 24-Hour Clinical Deterioration in Emergency Observation Patients: A Prospective Cohort Study.

Journal of multidisciplinary healthcare·2026
Same author

β-Hydroxybutyric acid impairs host antimicrobial defense by targeting the CEACAM1-NADPH-ROS axis to disrupt macrophage bactericidal activity.

Biochemical pharmacology·2026
Same author

Prediction of ALK, EGFR and KRAS mutations in lung adenocarcinoma based on PET/CT radiomics by cluster and synthetic minority over-sampling technique.

Medicine·2026
Same author

Correction: Intrabasin Variability of East Pacific Tropical Cyclones During ENSO Regulated by Central American Gap Winds.

Scientific reports·2026

Related Experiment Video

Updated: Jun 10, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Endothelial nitric oxide synthase polymorphisms and erectile dysfunction: a meta-analysis.

Jia-Li Wang1, Hai-Gang Wang, Hai-Qing Gao

  • 1Department of Emergency, Qilu Hospital, Shandong University, Jinan, China.

The Journal of Sexual Medicine
|August 21, 2010
PubMed
Summary
This summary is machine-generated.

The endothelial nitric oxide synthase G894T variant is linked to an increased risk of erectile dysfunction (ED). However, no significant association was found between the 4 VNTR polymorphism and ED susceptibility.

More Related Videos

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Related Experiment Videos

Last Updated: Jun 10, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

Area of Science:

  • Genetics
  • Molecular Biology
  • Urology

Background:

  • Erectile dysfunction (ED) significantly impacts quality of life.
  • Endothelial nitric oxide synthase (eNOS) gene polymorphisms are investigated for their role in ED susceptibility.
  • Previous studies on eNOS polymorphisms and ED risk have yielded conflicting results due to low statistical power.

Purpose of the Study:

  • To conduct a meta-analysis to estimate the association between eNOS variants and the risk of ED.
  • To consolidate evidence from existing studies to provide a more robust assessment of the eNOS-ED relationship.

Main Methods:

  • A systematic search of Medline and Embase databases was performed for studies on eNOS polymorphisms and ED.
  • Nine eligible articles were included in the meta-analysis.
  • Five genetic models and a generalized odds ratio (OR(G)) were used to analyze the association between eNOS G894T and 4 VNTR polymorphisms and ED risk.

Main Results:

  • The eNOS G894T variant showed a significant association with increased ED risk across most genetic models (allele contrast OR = 1.64, 95% CI: 1.03-2.60).
  • The meta-analysis using OR(G) also indicated a significant association (OR(G) = 1.64, 95% CI: 1.03-2.61).
  • No significant association was observed between the eNOS 4 VNTR polymorphism and ED risk (OR = 0.96, 95% CI: 0.72-1.28).

Conclusions:

  • The G894T variant of eNOS is associated with an increased risk of erectile dysfunction.
  • No significant association was found between the 4 VNTR polymorphism and ED.
  • Results should be interpreted cautiously, and further large-scale, well-designed studies are recommended for confirmation.